Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Net Cash Flow: 2016-2025

Historic Net Cash Flow for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to -$9.4 million.

  • Organogenesis Holdings' Net Cash Flow fell 310.45% to -$9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.6 million, marking a year-over-year decrease of 683.64%. This contributed to the annual value of $31.8 million for FY2024, which is 2935.59% up from last year.
  • Organogenesis Holdings' Net Cash Flow amounted to -$9.4 million in Q3 2025, which was up 74.56% from -$36.8 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Net Cash Flow registered a high of $41.2 million during Q4 2024, and its lowest value of -$36.8 million during Q2 2025.
  • Moreover, its 3-year median value for Net Cash Flow was $93,000 (2023), whereas its average is -$3.5 million.
  • In the last 5 years, Organogenesis Holdings' Net Cash Flow spiked by 1,116.13% in 2024 and then slumped by 3,353.67% in 2025.
  • Over the past 5 years, Organogenesis Holdings' Net Cash Flow (Quarterly) stood at $11.8 million in 2021, then plummeted by 140.08% to -$4.7 million in 2022, then soared by 216.53% to $5.5 million in 2023, then skyrocketed by 647.78% to $41.2 million in 2024, then plummeted by 310.45% to -$9.4 million in 2025.
  • Its last three reported values are -$9.4 million in Q3 2025, -$36.8 million for Q2 2025, and -$25.6 million during Q1 2025.